Global dissemination of FC-ϵ RI and p53 signalling perturbation contribute to Dasatinib resistance in Pancreatic Cancer Cell-lines
A K M Azad, Muhammad J. A. Shiddiky, Mohammad Ali Moni
This study identifies key signalling pathways and biomarkers associated with dasatinib resistance in pancreatic cancer using transcriptomics and network analysis.